<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: What a Week! Roche and Genentech &#8230; and Mirus!?!</title>
	<atom:link href="http://blog.pharmexec.com/2008/07/25/what-a-week-roche-genentech-andmirus/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2008/07/25/what-a-week-roche-genentech-andmirus/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 14:53:10 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Jeffrey Clark, CEO of Beaker.com - The Online Community for Life Sciences Professionals</title>
		<link>http://blog.pharmexec.com/2008/07/25/what-a-week-roche-genentech-andmirus/comment-page-1/#comment-5472</link>
		<dc:creator>Jeffrey Clark, CEO of Beaker.com - The Online Community for Life Sciences Professionals</dc:creator>
		<pubDate>Sat, 26 Jul 2008 22:23:35 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/2008/07/25/what-a-week-roche-genentech-andmirus/#comment-5472</guid>
		<description>As has been widely commented across the Web, the key to Roche&#039;s recent shopping spree will be the eventual integration of all these &#039;new toys&#039; into the Roche sandbox.  Mirus, Genentech and let&#039;s not forget Ventana Medical Systems.  Roche has never before (in my opinion) taken on such a vast &amp; complicated talent integration project.  

What will happen to their culture as a result? And, much, much more importantly:  will their new investment in people from these fantastic, performance-driven organizations adopt &amp; thrive within the One Roche environment?</description>
		<content:encoded><![CDATA[<p>As has been widely commented across the Web, the key to Roche&#8217;s recent shopping spree will be the eventual integration of all these &#8216;new toys&#8217; into the Roche sandbox.  Mirus, Genentech and let&#8217;s not forget Ventana Medical Systems.  Roche has never before (in my opinion) taken on such a vast &amp; complicated talent integration project.  </p>
<p>What will happen to their culture as a result? And, much, much more importantly:  will their new investment in people from these fantastic, performance-driven organizations adopt &amp; thrive within the One Roche environment?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

